Plasmodium vivax is an important cause of malaria, associated with a significant public
health burden. Whilst enhanced malaria-control activities have successfully reduced the …

In spite of significant progress towards malaria control and elimination achieved in South
America in the 2000s, this mosquito-transmitted tropical disease remains an important public …

Vivax malaria threatens patients despite relatively low-grade parasitemias in peripheral
blood. The tenet of death as a rare outcome, derived from antiquated and flawed clinical …

Malaria infection is still to be considered a major public health problem in those 106
countries where the risk of contracting the infection with one or more of the Plasmodium …

Introduction: Relapses are important contributors to illness and morbidity in Plasmodium
vivax and P. ovale infections. Relapse prevention (radical cure) with primaquine is required …

Plasmodium vivax is now the predominant species causing malarial infection and disease in
most non-African areas, but little is known about its transmission efficiency from human to …

Abstract Background Malaria transmission in Latin America is generally hypoendemic and
unstable, with Plasmodium vivax as the most prevalent species. However, only a few studies …

Malaria remains a significant public health problem worldwide, particularly in low-income
regions with limited access to healthcare. Despite the use of antimalarial drugs, transmission …

Background Malaria control activities can have a disproportionately greater impact on
Plasmodium falciparum than on P. vivax in areas where both species are coendemic. We …

Colombia aims to eliminate malaria by 2030 but remains one of the highest burden
countries in the Americas. Plasmodium vivax contributes half of all malaria cases, with its …